Correlation Between SAB Biotherapeutics and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Neoleukin Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Neoleukin Therapeutics.
Diversification Opportunities for SAB Biotherapeutics and Neoleukin Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Neoleukin is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Neoleukin Therapeutics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 21.5 times more return on investment than Neoleukin Therapeutics. However, SAB Biotherapeutics is 21.5 times more volatile than Neoleukin Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 5.40 in SAB Biotherapeutics on August 26, 2024 and sell it today you would earn a total of 1.90 from holding SAB Biotherapeutics or generate 35.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 42.4% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Neoleukin Therapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Neoleukin Therapeutics
The main advantage of trading using opposite SAB Biotherapeutics and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |